Detection of low-grade prosthetic joint infections using 99mTc-antigranulocyte SPECT/CT: initial clinical results
- 561 Downloads
Low-grade joint infections are characterized by infiltration of granulocytes, which mediate aspects of inflammatory changes. We evaluated retrospectively the contribution of SPECT/CT as an addition to planar scintigraphy with 99mTc-labelled antigranulocyte antibodies for diagnosing and localizing low-grade joint infections.
Planar scintigraphy using 99mTc-labelled antigranulocyte BW 250/183 antibodies was performed in 31 patients with suspected joint infections at 5 min, 5 h and 24 h after injection, with additional SPECT/CT performed 6 h after injection. With reference to gold standard clinical data, we assessed the diagnostic sensitivity of scintigraphy alone and in conjunction with SPECT/CT.
Joint infections were diagnosed clinically in 9 of the 31 patients (1 hip and 8 knee prostheses). Planar scintigraphy revealed 6 true-positives, 13 true-negatives, 9 false-positives and 3 false-negative results, indicating sensitivity, specificity, positive and negative predictive values of, respectively, 0.66, 0.60, 0.4 and 0.81. With the addition of SPECT images, corresponding sensitivity, specificity, positive and negative predictive values increased to 0.89, 0.45, 0.40 and 0.91. Implementation of fused SPECT/CT led to a further increase to 0.89, 0.73, 0.57 and 0.94.
Relative to planar scintigraphy, SPECT with and without CT substantially improved the utility of imaging with 99mTc-labelled antigranulocyte antibodies for diagnosis and localization of suspected joint infections. Optimal accuracy was obtained through image fusion, which permitted anatomical allocation of foci of pathological tracer accumulation as well as providing information on the extent of the infection. This imaging method seems suited for selection of patients requiring surgical therapy.
KeywordsAntigranulocyte scintigraphy SPECT/CT Low-grade Joint infection
The authors thank Dr. Paul Cumming for critical revisions of the manuscript.
- 4.Ivanćević V, Perka C, Hasart O, Sandrock D, Munz DL. Imaging of low-grade bone infection with a technetium-99m labelled monoclonal anti-NCA-90 Fab′ fragment in patients with previous joint surgery. Eur J Nucl Med Mol Imaging 2002;29:547–51. doi: 10.1007/s00259-001-0744-7.CrossRefPubMedGoogle Scholar
- 9.Kaisidis A, Megas P, Apostolopoulos D, Spiridonidis T, Koumoundourou D, Zouboulis P, et al. Diagnosis of septic loosening of hip prosthesis with LeukoScan. SPECT scan with 99mTc-labeled monoclonal antibodies. Orthopade 2005;34:462–9. German. doi: 10.1007/s00132-005-0777-x.CrossRefPubMedGoogle Scholar
- 12.Rubello D, Casara D, Maran A, Avogaro A, Tiengo A, Muzzio PC. Role of anti-granulocyte Fab′ fragment antibody scintigraphy (LeukoScan) in evaluating bone infection: acquisition protocol, interpretation criteria and clinical results. Nucl Med Commun 2004;25:39–47. doi: 00006231-200401000-00006 [pii].CrossRefPubMedGoogle Scholar
- 13.Vicente AG, Almoguera M, Alonso JC, Heffernan AJ, Gomez A, Contreras PI, et al. Diagnosis of orthopedic infection in clinical practice using Tc-99m sulesomab (antigranulocyte monoclonal antibody fragment Fab′2). Clin Nucl Med 2004;29:781–5. doi: 00003072-200412000-00001 [pii].CrossRefPubMedGoogle Scholar
- 20.Pakos EE, Trikalinos TA, Fotopoulos AD, Ioannidis JP. Prosthesis infection: diagnosis after total joint arthroplasty with antigranulocyte scintigraphy with 99mTc-labeled monoclonal antibodies—a meta-analysis. Radiology 2007;242:101–8. doi: 2421052011 [pii] 10.1148/radiol.2421052011.CrossRefPubMedGoogle Scholar